COVID-19 Update: The Center for Professional Innovation & Education

March 24, 2020

Dear CfPIE Customers:



During this difficult and often confusing time, our primary concern lies with the health and safety of our customers and employees. We are closely monitoring guidance from the CDC and other health organizations regarding how best to keep everyone safe. 

Presently, we have canceled or postponed all of our courses through the end of April and will continue to monitor the situation if that decision needs to be continued into May or later.


Realizing that most of our customers do not wish to travel, and our European customers cannot travel to the U.S., we will be setting up systems so that you’ll have the option of remotely connecting to our training session from your home or office.

This decision should allow everyone to either attend a course if they are local to our training site or connect remotely if they prefer. We’ve had numerous requests from customers to connect remotely so that their progress towards earning their Certification is not interrupted. 

We are looking forward to resuming our live training classes as soon as possible and will periodically update you. In the meantime, we wish you and your loved ones good health.


Best regards,

Mark G. Mazzie
CEO, The Center for Professional Innovation & Education

paper_plane

Need more information on our life-science training course?

Get In Touch With Us Today!

Contact Us

Blog Categories

Operational Excellence and Sustained Procedural Discipline
November 5, 2026
Pharmaceutical workforce readiness and operational excellence are vital for product quality and safety. Learn more about preventing FDA Warning Letters.
Gap 4: What FDA Warning Letters Reveal About Data Integrity and Scientific Documentation
November 4, 2026
FDA Warning Letters show how incomplete or unreliable data can undermine investigations, batch decisions, oversight, and the pharmaceutical quality system.